Chief Executive Officer of Chris Veihbacher of French drugs group Sanofi Aventis speaks during a news conference in Paris, September 24, 2009. Sanofi announced the results of the collaborative AIDS vaccine trial that has been conducted in Thailand over the past six years. The vaccine, made from a combination of Sanofi-Pasteur's ALVAC canary pox vaccine and the failed HIV vaccine AIDSVAX, has made major progress in finding an effective way to combat the illness, researchers said on Thursday. REUTERS/Charles Platiau (FRANCE BUSINESS HEALTH HEADSHOT)
Reuters/CHARLES PLATIAU